Doctors News Hubb
Advertisement Banner
  • Home
  • News
  • Healthcare
  • Public Health
  • Paramedic
  • Nursing
  • Contact Us
No Result
View All Result
  • Home
  • News
  • Healthcare
  • Public Health
  • Paramedic
  • Nursing
  • Contact Us
No Result
View All Result
Doctors News Hubb
No Result
View All Result
Home News

Management of Axial Disease in Psoriatic Arthritis

admin by admin
April 19, 2023
in News


The following is a summary of the “Management of Axial Disease in Patients With Psoriatic Arthritis: An Updated Literature Review Informing the 2021 GRAPPA Treatment Recommendations,” published in the February 2023 issue of Rheumatology by Lubrano, et al.


Axial involvement in patients with psoriatic arthritis (PsA) is a common subset of this condition, but a unanimous definition has yet to be established. It has been defined by using different criteria, ranging from the presence of at least unilateral grade 2 sacroiliitis to those used for ankylosing spondylitis (AS) or simply the presence of inflammatory low back pain (IBP). They aimed to identify and evaluate the efficacy of therapeutic interventions for treating axial disease in PsA.

This systematic review is an update of the axial PsA (axPsA) domain of the treatment recommendations project by the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA). The systematic review of the literature showed that new biologic and targeted synthetic disease-modifying antirheumatic drug classes, namely interleukin (IL)-17A and Janus kinase inhibitors, could be considered for the treatment of axPsA. 

Nonsteroidal anti-inflammatory drugs (NSAIDs), physical therapy (PT), simple analgesia, and anti-tumor necrosis factor drugs (TNF antagonists) would be used in addition to this. Conflicting evidence remains regarding using IL-12/23 and IL-23 inhibitors. Further studies are needed for a better understanding of the treatment of axPsA, as well as validated outcome measures.

Source: jrheum.org/content/50/2/279



Source link

Advertisement Banner
Previous Post

The Critical Role of Charting in Nursing

Next Post

Two Cases of a Cool Skin Condition (Erythrocyanosis, Pernio or Chilblains, Anyone?) – The Health Care Blog

Related Posts

News

Factors Associated with Recurrences or Relapses in Individuals Diagnosed with GCA

June 1, 2023
News

Examining Independently Billed Dermatologic Procedures by Nonphysician Practitioners in the US

May 31, 2023
News

Long-Term Use of Antiseizure Medication and the Risk of Developing Type 2 Diabetes Mellitus

May 30, 2023
News

TC Response in IBD Children Treated with Infliximab and Adalimumab After Treatment Adjustment

May 29, 2023
News

Spironolactone may be effective in the treatment of acne vulgaris

May 28, 2023
News

Quizartinib improves overall median survival in patients with acute myeloid leukemia

May 27, 2023
Next Post

Two Cases of a Cool Skin Condition (Erythrocyanosis, Pernio or Chilblains, Anyone?) – The Health Care Blog

Recommended

CMS cracks down on the nation’s poorest-performing nursing homes

7 months ago

Young Adults with High Long-Term But Low Short-Term Risk for ASCVD Incidence

1 month ago

Later Neurodevelopmental and Health Outcomes in the Growth After Extremely Preterm Births

3 months ago

Point32Health faces cybersecurity ransomware attack

1 week ago

Why health systems may never recover pre-COVID inpatient volumes

3 months ago

© Doctors News Hubb All rights reserved.

Use of these names, logos, and brands does not imply endorsement unless specified. By using this site, you agree to the Privacy Policy and Terms & Conditions.

Navigate Site

  • Home
  • News
  • Healthcare
  • Public Health
  • Paramedic
  • Nursing
  • Contact Us

Newsletter Sign Up.

No Result
View All Result
  • Home
  • News
  • Healthcare
  • Public Health
  • Paramedic
  • Nursing
  • Contact Us

© 2022 Doctors News Hubb All rights reserved.